Study of serum cholinesterase as a biomarker in a sample of patients with viral hepatitis B or hepatitis C in Baghdad

The most prevalent illnesses that affect the liver are viral infections; when cell is destroyed by viruses, it loses its function and of body's processes compromised. primary source serum cholinesterase. Therefore, cholinesterase can be used as a predictive biomarker for liver's synthetic capability. This study aims to evaluate in patients with hepatitis B virus (HBV) or C (HCV). was conducted at Gastroenterology Hepatology Teaching Hospital Poisoning Consultation Center Baghdad during interval from November 2021 March 2022. tests were measured one hundred fifty samples. Fifty HBV HCV compared healthy individuals control group. mean patient groups (8528.76±2000.45 U/L 7494.12± 2586.30 U/L, respectively) lower than group (9380.12±1848.96 U/L), difference statistically significant (P < 0.05). (7494.12±2586.30 U/L) significantly 0.05) (8528.76 ±2000.45 U/L).